Individual results vary, but outcomes are clinically predictable with proper monitoring, lifestyle support, and attentive follow up
If a different approach would be more suitable, the physician will recommend that instead
OATP1B1 exhibits the broadest substrate specificity, while other subtypes display more selective affinities
It stimulates the Akt/mTOR pathway, promoting cell survival and apoptosis inhibition
Weight-related comorbidities that qualify include type 2 diabetes, hypertension (high blood pressure), dyslipidemia (high cholesterol or triglycerides), obstructive sleep apnea, cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), and osteoarthritis of weight-bearing joints
Kumar recommends working with your provider to assess how well you tolerate each drug, as well as the severity of your diagnosis, whether thats diabetes, obesity, or something else